U.S. Markets open in 26 mins

American Airlines (AAL) Stock Declines 18% YTD: Here's Why

Zacks Equity Research
1 / 2

Is Etsy (ETSY) Outperforming Other Computer and Technology Stocks This Year?

Is (ETSY) Outperforming Other Computer and Technology Stocks This Year?

Shares of American Airlines Group Inc. AAL have lost 17.5% so far this year, underperforming its industry's decline of 11.8%.

YTD Price Performance

Reasons Behind the Lackluster Price Performance

High fuel costs have been the primary reason behind the company’s dismal performance.In fact, oil prices have increased roughly 10% on a year-to-date basis.

In the second quarter, high fuel costs are expected to limit bottom-line growth at American Airlines as was the case in first-quarter 2018. Average fuel price per gallon rose 23.6% year over year to $2.10 per gallon in the first quarter. Fuel prices are anticipated to be even higher (between $2.18 and $2.23 per gallon) in the second quarter.

Apart from high fuel costs, expenses pertaining to labor are expected to weigh on the bottom line in the second quarter. Consolidated cost per available seat miles (excluding special items and fuel) is anticipated to increase 3.5% in the second quarter of 2018.

American Airlines’ high debt levels are added concerns. Apart from American Airlines, the rise in oil prices has also hurt other airline operators like Southwest Airlines Co. LUV, Delta Air Lines, Inc. DAL and United Continental Holdings, Inc. UAL.

Other Unfavorable Readings

The Zacks Consensus Estimate for second-quarter and full-year 2018 earnings moved south 8.5% and 7.9%, respectively, in the last 60 days. This reflects investor’s pessimism surrounding the stock. 

Furthermore, the company’s Momentum Score of D highlights its short-term unattractiveness. Undoubtedly, the above negatives substantiate the company’s Zacks Rank #4 (Sell).

You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

5 Medical Stocks to Buy Now

Zacks names 5 companies poised to ride a medical breakthrough that is targeting cures for leukemia, AIDS, muscular dystrophy, hemophilia, and other conditions.

New products in this field are already generating substantial revenue and even more wondrous treatments are in the pipeline. Early investors could realize exceptional profits.

Click here to see the 5 stocks >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Southwest Airlines Co. (LUV) : Free Stock Analysis Report
 
Delta Air Lines, Inc. (DAL) : Free Stock Analysis Report
 
United Continental Holdings, Inc. (UAL) : Free Stock Analysis Report
 
American Airlines Group Inc. (AAL) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.